Daniel L. Alkon serves as Executive at Neurotrope, Inc., where they oversee executive responsibilities. Since joining the company, Daniel L. Alkon has executed 5 insider transactions totaling $105.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Dec 16, 2022 involved selling 19,688 shares valued at $23.0K.
Daniel L. Alkon currently holds 35,546 shares of Neurotrope, Inc. (NTRP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Daniel L. Alkon has been a net buyer of NTRP stock. They have purchased $82.6K and sold $23.0K worth of shares.
Daniel L. Alkon's most recent insider trade was on Dec 16, 2022, when they sold 19,688 shares at $1.17 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 13, 2021 | SNPX | $0 | Award | 80,000 | $N/A | Discretionary |
| Jun 14, 2021 | SNPX | $82.6K | Purchase | 10,000 | $8.26 | Discretionary |
| Dec 1, 2020 | NTRP | $0 | Disposition | 29,688 | $N/A | Discretionary |